Last reviewed · How we verify
Water sucking
Water sucking drug is not a known pharmaceutical drug, but it could be a hypothetical drug that increases water absorption in the body.
At a glance
| Generic name | Water sucking |
|---|---|
| Also known as | Eau ppi, BRAUN |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
This hypothetical drug would likely work by increasing the expression or activity of aquaporins, proteins that facilitate water transport across cell membranes.
Approved indications
Common side effects
Key clinical trials
- Mother-Baby Study - Observational (NA)
- The Effectiveness of Guided Botulinum Toxin "A" Injection to the Masticatory Muscles in the Management of Condylar and Subcondylar Fractures (NA)
- This Randomized, Single-center Trial Aims to Evaluate the Advantages of Underwater ESD (U-ESD) in Comparison to the Conventional ESD (C-ESD). (NA)
- Direct Swallowing Training and Oral Sensorimotor Stimulation in Preterm Infants (NA)
- Echinaforce COVID-19 Shedding Study (PHASE4)
- Comparison of the Efficiency of Two Different Methods in Managing Early Postoperative Thirst (NA)
- MIME THERAPY vs MOTOR IMAGERY TECHNIQUE in Bell's Palsy (NA)
- Treatment of Upper Urinary Tract Stones With a Diameter≤2cm by Intelligent Pressure-controlled Flexible Ureteroscope (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Water sucking CI brief — competitive landscape report
- Water sucking updates RSS · CI watch RSS
- Centre Hospitalier Universitaire de Saint Etienne portfolio CI